Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY: MED )

13.87 -0.18 (-1.28%)
Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 Next >
Medifast Named as One of The “Best Companies To Work For” by U.S. News & World Report
From Medifast
Via Business Wire
3 Stocks to Sell as Ozempic Surges in Popularity
GLP-1s are a weight-loss breakthrough, but these three stocks to sell have a lot to lose from their rapid rise in popularity. 
Via InvestorPlace
7 Small-Cap Value Stocks Leaving the S&P 500 in the Dust
These small-cap value stocks remain an overlooked market segment despite their inherent strength and outperformance likelihood. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Looking Into Medifast's Recent Short Interest
Via Benzinga
(MED) - Analyzing Medifast's Short Interest
Via Benzinga
How Is The Market Feeling About Medifast?
Via Benzinga
(MED) - Analyzing Medifast's Short Interest
Via Benzinga
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
KKR and GoDaddy also will join before the open on June 24. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
7 Underappreciated Stocks With 25% Return Potential in 2024
Each of these underappreciated stocks is expected to provide 25%+ returns this year, which is reason enough to pay attention. 
Via InvestorPlace
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result 
Via MarketBeat
Invest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street Wrong
These undervalued stocks to buy offer an alternative to dipping your toes back into meme stock mania. Remember how it turned out last time? 
Via InvestorPlace
Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
From Medifast
Via Business Wire
Pocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to Roar
Small-cap value stocks offer stability and continued upside as big-name stocks soak up investor attention despite overvaluation. 
Via InvestorPlace
Top 4 Defensive Stocks You'll Regret Missing This Quarter
Via Benzinga
Gold Down Over 2%; 3M Profit Beats Expectations
Via Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Dips Over 100 Points; Coca-Cola Earnings Top Views
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
From Schall Law
Via GlobeNewswire
Dow Tumbles 200 Points; McDonald's Posts Downbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Coursera (COUR) Stock Down 16% Today?
Coursera stock is falling on Tuesday as COUR investors react to the company's lackluster guidance in its latest earnings report. 
Via InvestorPlace
Why Is Medifast (MED) Stock Down 20% Today?
Medifast stock is down on Tuesday after the company released mixed results for Q1 2024 alongside a weak outlook for Q2 2024. 
Via InvestorPlace
Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today! 
Via InvestorPlace
Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
MED Stock Earnings: Medifast Misses EPS, Beats Revenue for Q1 2024
MED stock results show that Medifast missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Medifast Announces First Quarter 2024 Financial Results
From Medifast, Inc.
Via Business Wire
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
From Medifast
Via Business Wire
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Hey, Bottom Fishers! 3 Beaten Up Stocks to Buy for Short-Term Gains
These three companies are beaten up stocks to buy, as their oversold status and solid fundamentals make them attractive picks. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.